Publicacións (108) Publicacións nas que participase algún/ha investigador/a

2023

  1. 18F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography Findings of Polymyalgia Rheumatica in Patients with Giant Cell Arteritis

    Journal of Clinical Medicine, Vol. 12, Núm. 22

  2. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 1, pp. 48-56

  3. A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 974-984

  4. A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

    Arthritis Research and Therapy, Vol. 25, Núm. 1

  5. Abatacept in usual and in non-specific interstitial pneumonia associated with rheumatoid arthritis

    European Journal of Internal Medicine

  6. Alpha-Klotho protein in systemic lupus erythematosus

    Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 41-47

  7. Ampicillin Stability in a Portable Elastomeric Infusion Pump: A Step Forward in Outpatient Parenteral Antimicrobial Therapy

    Pharmaceutics, Vol. 15, Núm. 8

  8. An Atlas of the Knee Joint Proteins and Their Role in Osteoarthritis Defined by Literature Mining

    Molecular and Cellular Proteomics, Vol. 22, Núm. 8

  9. Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort study

    Biomedicine and Pharmacotherapy, Vol. 157

  10. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients

    Seminars in Arthritis and Rheumatism, Vol. 58

  11. Anti-inflammatory potential of ulvan

    International Journal of Biological Macromolecules, Vol. 253

  12. Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects

    Frontiers in Endocrinology, Vol. 13

  13. Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression

    Arthritis Research and Therapy, Vol. 25, Núm. 1

  14. Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology Alliance

    Arthritis Care and Research, Vol. 75, Núm. 1, pp. 53-60

  15. Association of vocational interventions and work-related factors with disease and work outcomes in people with RMDs: A systematic review

    Seminars in Arthritis and Rheumatism, Vol. 58

  16. Audiovestibular Manifestations in Patients with Primary Raynaud’s Phenomenon and Raynaud’s Phenomenon Secondary to Systemic Sclerosis

    Journal of Clinical Medicine, Vol. 12, Núm. 9

  17. Biomedical Applications of the Biopolymer Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): Drug Encapsulation and Scaffold Fabrication

    International Journal of Molecular Sciences, Vol. 24, Núm. 14

  18. Blood Composite Scores in Patients with Systemic Lupus Erythematosus

    Biomedicines, Vol. 11, Núm. 10

  19. Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    Seminars in Arthritis and Rheumatism, Vol. 58

  20. Challenges in the diagnosis of polymyalgia rheumatica and related giant cell arteritis

    Expert Review of Clinical Immunology, Vol. 19, Núm. 5, pp. 517-526